SCHEMBL17356502

SCHEMBL17356502

CCOP(=O)(CCC(=O)Oc1ccc(F)c(C(F)(F)F)c1)OCC

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 1/20 0.37
SLC6A4 P31645 1/20 0.37
KCNH2 Q12809 1/20 0.37
KCNN4 O15554 1/20 0.34
EPHX2 P34913 2/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
PTPN7 P35236 1/20 0.34
DUSP3 P51452 1/20 0.34
CDK8 P49336 1/20 0.34
KMT2A Q03164 2/20 0.33
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
LMNA P02545 1/20 0.33
MAPT P10636 1/20 0.33
HTT P42858 1/20 0.33
HSD17B10 Q99714 1/20 0.33
TAS1R3 Q7RTX0 1/20 0.33
TAS1R1 Q7RTX1 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17356501 0.88 HTR2A (0.40) HTR2ASLC6A4KCNH2KCNN4EPHX2
SCHEMBL17352172 0.88 HTR2A (0.36) HTR2ASLC6A4KCNH2KCNN4EPHX2
SCHEMBL17355840 0.84 KMT2A (0.38) HTR2ASLC6A4KCNH2NPC1RAB9A
SCHEMBL17356446 0.82 BCL9 (0.46) HTR2ASLC6A4KCNH2PTPN7DUSP3
SCHEMBL17352167 0.82 MAPT (0.44) HTR2ASLC6A4KCNH2EPHX2PTPN7
SCHEMBL17356437 0.79 ACHE (0.47) HTR2ASLC6A4KCNH2SMN1; SMN2PTPN7
SCHEMBL17356326 0.79 KMT2A (0.41) HTR2ASLC6A4KCNH2PTPN7DUSP3
SCHEMBL17352131 0.79 KMT2A (0.45) HTR2ASLC6A4KCNH2PTPN7DUSP3
SCHEMBL17356506 0.79 PTPN7 (0.40) HTR2ASLC6A4KCNH2KCNN4EPHX2
SCHEMBL17355664 0.78 MAPT (0.42) HTR2ASLC6A4KCNH2EPHX2PTPN7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150372349-A1 NON-AQUEOUS ELECTROLYTE AND ELECTRICITY STORAGE DEVICE UBE INDUSTRIES, LTD. (JP) 2015-12-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150372349-A1 NON-AQUEOUS ELECTROLYTE AND ELECTRICITY STORAGE DEVICE HCN2, SCO2, HCN1 HTR2A 4567/4885SLC6A4 2741/4885KCNH2 4/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.